Home › Funds › Soleus Capital Management, L.P. › EOLS
Soleus Capital Management, L.P. position in EOLS
EVOLUS INC · Health Care
Soleus Capital Management, L.P. reported holding 5,090,000 shares of EOLS (EVOLUS INC) in its Q3 2026 13F filing — a position valued at US$40.7M, representing 1.45% of its reported portfolio and ranking #18 among its reported holdings. Soleus Capital Management, L.P. has disclosed EOLS holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s EOLS position evolved
Soleus Capital Management, L.P. first disclosed a stake in EOLS in Q3 2023 at 2,078,000 shares (US$19.0M). The position peaked in Q3 2026 at 5,090,000 shares, worth US$40.7M. Across 12 filings, Soleus Capital Management, L.P. increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 5,090,000 shares valued at US$40.7M — an increase of 4,267,572 shares quarter over quarter.. Notable position changes include a 620% increase in Q2 2024 (shares rose 49% over the following quarter), a 110% increase in Q1 2026 (shares rose 69% over the following quarter), a 519% increase in Q3 2026 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.08M | $18.99M | New |
| Q1 2024 | 160.00K | $2.24M | New |
| Q2 2024 | 1.15M | $12.50M | Add |
| Q3 2024 | 1.04M | $16.81M | Reduce |
| Q4 2024 | 697.16K | $7.70M | Reduce |
| Q1 2025 | 1.08M | $12.98M | Add |
| Q2 2025 | 2.12M | $19.52M | Add |
| Q3 2025 | 1.45M | $8.90M | Reduce |
| Q4 2025 | 1.07M | $7.12M | Reduce |
| Q1 2026 | 2.25M | $9.23M | Add |
| Q2 2026 | 822.43K | $5.71M | Reduce |
| Q3 2026 | 5.09M | $40.72M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EOLS and 13F data
EOLS (EVOLUS INC) is a Health Care company. 21 other funds we track also report a position in EOLS — the largest reported positions include Nantahala Capital Management, LLC (US$50.0M), BRAIDWELL LP (US$24.7M), Frazier Life Sciences Management, L.P. (US$21.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EOLS
- Nantahala Capital Management, LLC 6.24M sh · $49.96M · Q3 2026
- BRAIDWELL LP 3.08M sh · $24.67M · Q3 2026
- Frazier Life Sciences Management, L.P. 2.63M sh · $21.05M · Q3 2026
- PERCEPTIVE ADVISORS LLC 2.46M sh · $19.67M · Q3 2026
- Stonepine Capital Management, LLC 500.00K sh · $5.00M · Q3 2026
- AWH Capital, L.P. 625.00K sh · $5.00M · Q3 2026
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held EOLS?
Soleus Capital Management, L.P. has disclosed EOLS holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
What is Soleus Capital Management, L.P.'s current position in EOLS?
As of Q3 2026, Soleus Capital Management, L.P. holds 5.09M shares of EOLS (EVOLUS INC), valued at $40.72M, representing 1.45% of its reported portfolio and ranking #18.
Has Soleus Capital Management, L.P. been buying or selling EOLS?
In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. increased its position in EOLS. The position peaked in Q3 2026 at 5.09M shares.
Which other funds hold EOLS?
Other major institutional holders of EOLS include Nantahala Capital Management, LLC, BRAIDWELL LP, Frazier Life Sciences Management, L.P., among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.